Effectiveness of a Physical Activity Program (EPAP)
17 de junho de 2026 atualizado por: Federal University of Pará
Effectiveness of a Physical Activity Program in Adults and the Elderly
study with multicomponent exercise
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
The objective of this research is to evaluate the effectiveness of a multicomponent physical activity program on the physical fitness of adults and the elderly.
Participants will be adults and elderly individuals who perform physical activities in an extension project at the Federal University of Pará, Castanhal Campus, three times a week for 60 minutes.
Each class will emphasize two physical capacities.
Physical assessments will take place at the beginning and end of the school year and will include evaluations of the participants' profile, anthropometry, physical capacities, blood pressure, handgrip strength, and mental health.
This research project aims to achieve the following goals: Conduct at least 80 assessments each year; Improve quality of life; Improve physical capacities; Reduce body circumferences; Improve muscle strength and handgrip strength; Encourage the participation of Physical Education students in research projects; Guide students in scientific work and in the preparation of their Final Course Projects; Participate in scientific events with presentations of work resulting from this research.
Keywords: Adults; elderly people; physical activity; physical abilities.
Tipo de estudo
Intervencional
Inscrição (Real)
20
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Pará
-
Castanhal, Pará, Brasil, 68746-630
- Universidade Federal do Pará
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Adults
- Older adults
- Over 50 years of age of both sexes
- Participating in an extension program at Federal University of Pará
- Self-reported diagnosis of hypertension.
Exclusion Criteria:
- Participants who did not agree with the study
- Participants Who have low attendance in classes (below 50%).
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Intervention Group (IG)
The IG followed this protocol: Week 1 - Day 1: thirty minutes of aerobic resistance exercises and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises. Week 2 - Day 1: thirty minutes of strength exercises for upper and lower limbs and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises. After week 2, the training returned to week 1 until completing ten weeks. The balance exercises used in the classes were static and dynamic, with 6 to 7 exercises and a duration of 30 to 45 minutes. In the first three weeks, the balance exercises were performed with two sets of 12 to 15 repetitions. From the fourth week onwards, there was a progression to three sets of 12 repetitions, and in the last four weeks, the exercises were performed with four sets of 12 repetitions. |
Participants who were randomized to the intervention group performed 10 weeks of body balance exercise.
Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.
|
|
Comparador Ativo: Control
Week 1 - Days 1 and 2: 30 minutes of aerobic endurance exercises and 30 minutes of flexibility exercises. Week 2: Days 1 and 2: 30 minutes of strength training for upper and lower limbs and 30 minutes of balance exercises. After week 2, the training returned to week 1 until completing the ten weeks. |
Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in lower limb muscle strength
Prazo: Baseline and after 10 weeks
|
The assessments included tests of lower limb strength (sit-to-stand test) - In this test, the participant must sit down and stand up from a chair.
The total number of repetitions in 30 seconds is recorded.
|
Baseline and after 10 weeks
|
|
Change in upper limb strength
Prazo: Baseline and 10 weeks
|
Upper limb strength (forearm flexion test) - The forearm flexion test assesses upper body strength using two-kilogram dumbbells for women and four-kilogram dumbbells for men, a chair with a backrest (without armrests), and a stopwatch.
The participant must be seated against the chair with an upright posture, performing the greatest number of bicep curls with their dominant hand in thirty seconds.
|
Baseline and 10 weeks
|
|
Change in lower limb flexibility
Prazo: Baseline and 10 weeks
|
Lower limb flexibility (sit-and-reach test) - With the leg extended (but not overextended), the participant slowly leans forward, keeping the spine as straight as possible and the head aligned with the spine.
The participant attempts to touch their toes by sliding their hands, one on top of the other, with the tips of their middle fingers, down the extended leg.
The evaluator uses a 45 cm ruler and records the distance (cm) to the toes (minimum result) or the distance (cm) that can be reached beyond the toes (maximum result).
|
Baseline and 10 weeks
|
|
Change in body balance
Prazo: Baseline and 10 weeks
|
agility/dynamic balance (sit-to-walk 2.44m and return to sit test) - The person being evaluated starts in a seated position in a chair with an upright posture, hands on thighs and feet on the floor with one foot slightly in front of the other.
At the signal, the person being evaluated gets up from the chair (they can push off with their thighs or the chair), walks as quickly as possible around the cone, returns to the chair and sits down.
For reliable timing, the evaluator should start the stopwatch at the signal movement, whether or not the person has started moving, and stop the stopwatch the exact moment the person sits down in the chair.
|
Baseline and 10 weeks
|
|
Change in upper limb flexibility
Prazo: Baseline and 10 weeks
|
Upper limb flexibility (behind-the-back reach test) - Standing, the subject places their preferred hand on the same shoulder, palm open and fingers extended, reaching as far as possible to the middle of their back (elbow pointing upwards).
The hand of the other arm is placed behind the back, palm upwards, reaching upwards as far as possible in an attempt to touch or overlap the extended middle fingers of both hands.
Without moving the subject's hands, the evaluator helps to verify if the middle fingers of each hand are pointing towards each other.
The overlap distance, or the distance between the tips of the middle fingers, is measured to the nearest centimeter.
Negative results (-) represent the shortest distance between the middle fingers; positive results (+) represent the overlap of the middle fingers.
|
Baseline and 10 weeks
|
|
Change in aerobic endurance
Prazo: Baseline and 10 weeks
|
Aerobic endurance (6-minute walk) - At the indicated signal, participants walk as fast as possible (without running) around the course as many times as they can within the time limit.
During the test, participants may stop and rest if necessary, and then resume walking.
The evaluator must move onto the course after all participants have started and must record the elapsed time.
The 6-minute walk test uses a 45.7 m course measured in 4.57 m segments.
The distance covered in the 6-minute interval will be assessed.
|
Baseline and 10 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in body mass
Prazo: Baseline and 10 weeks
|
Body mass (BM) - measurement obtained in kilograms using a digital scale.
|
Baseline and 10 weeks
|
|
Height Assessment
Prazo: Baseline and 10 weeks
|
Height (meters) - will be obtained using a stadiometer.
|
Baseline and 10 weeks
|
|
Change in waist circumference
Prazo: Baseline and 10 weeks
|
waist circumference (WC) - measurement obtained in centimeters using a measuring tape
|
Baseline and 10 weeks
|
|
Change in hip circumference
Prazo: Baseline and 10 weeks
|
Hip circumference (HC) - a measurement obtained in centimeters using a measuring tape.
|
Baseline and 10 weeks
|
|
Change in Body Mass Index (BMI)
Prazo: Baseline and 10 weeks
|
Body Mass Index (BMI) - will be assessed by dividing body mass in kilograms by height squared in meters.
|
Baseline and 10 weeks
|
|
Change in Percentage of fat
Prazo: Baseline and 10 weeks
|
Percentage of fat (%BF) - a measurement obtained as a percentage using a bioimpedance scale.
|
Baseline and 10 weeks
|
|
Change in percentage of skeletal muscle
Prazo: Baseline and 10 weeks
|
Percentage of skeletal muscle (%SM) - a measurement obtained as a percentage using a bioimpedance scale.
|
Baseline and 10 weeks
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
25 de agosto de 2025
Conclusão Primária (Real)
18 de setembro de 2025
Conclusão do estudo (Real)
2 de dezembro de 2025
Datas de inscrição no estudo
Enviado pela primeira vez
29 de maio de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
17 de junho de 2026
Primeira postagem (Real)
23 de junho de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
23 de junho de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
17 de junho de 2026
Última verificação
1 de junho de 2026
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- EPAP
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .